Shewanella putrefaciens is as yet rarely responsible for clinical syndromes in humans. However, a case involving multiple organs in an elderly male under treatment with appropriate steroids confirms that attention should be devoted to unusual pathogens. CASE REPORTAn 87-year-old Caucasian male who had come back a few days before from holidays on the Adriatic shore was admitted because of shivering, fever up to 39.8°C, and erysipelas of the left forearm. He complained of malaise, extreme weakness, and severe pain at the upper left extremity. No other relevant symptoms were present. There was a history of "rheumatic myalgia" (not well diagnosable) for which he was on long-term, low-dose methylprednisolone (4 mg once daily); he denied other previous illnesses of note and regular consumption of any drugs.On exam, he presented as an obese man with a typical Cushing-like face and was febrile (39°C) but hemodynamically stable. A 1.5-cm-long cutaneous-subcutaneous wound was present on the skin near the left elbow, together with erysipelas affecting the whole left forearm. Small-bubbled rattling noises were heard at the level of the left pulmonary basis. In view of the fever, immediate blood (three sets each in aerobic and anaerobic bottles) (BD BACTEC, Benex Ltd., Shannon, Ireland), urine, and stool cultures were taken. Wound exudate was not cultured, nor was skin biopsy performed. Hematological investigations revealed a white cell count of 13.9 ϫ 10 9 / liter, a hemoglobin level of 14.0 g/dl, and a platelet count of 167 ϫ 10 9 /liter. C-reactive protein was at 13.5 mg/dl (normal range, 0 to 0.5 mg/dl), and the erythrocyte sedimentation rate was 37 mm (normal range, 0 to 10 mm). Chest X-ray film showed a segmental infiltrate in the left lower lobe very close to the diaphragm muscle and consistent with pneumonia. No sputum cultures were obtained, and the stable general conditions of the patient suggested delaying a bronchoscopy in order to recover lung aspirate. The patient was given empirical antimicrobial therapy with intravenous
A stillborn male infant with cyclopia, holoprosencephaly, extracephalic malformations, and trisomy 18 is described. The importance of chromosome studies in infants with severe congenital malformations is discussed.
The objective of the study presented here was to compare antimicrobial use and resistance of bacterial isolates in the haematology ward and the intensive care unit of Bolzano General Hospital. The bacterial organisms isolated most frequently from patients in the two wards (coagulase-negative staphylococci, Enterococcus spp., and Pseudomonas aeruginosa) were investigated for antimicrobial resistance. Isolates obtained from patients in the haematology ward were more often resistant to antimicrobial agents than isolates obtained from patients in the intensive care unit, and the agents against which the highest rates of resistance were found were third-and fourth-generation cephalosporins, carbapenems and monobactams, quinolones, aminoglycosides, and trimethoprim-sulfamethoxazole. These classes of antimicrobial agents were also used more frequently in the haematology ward than in the intensive care unit. Conversely, penicillinic β-lactam antibiotics, rifamycins, macrolides and lincosamides were used less frequently in the haematology ward than in the intensive care unit, and the rates of resistance against these classes of antimicrobial agents were significantly lower in the haematology ward than in the intensive care unit. The results support the hypothesis that a causal relationship exists between antimicrobial use and the development of resistance and indicate that careful monitoring of antimicrobial use in hospitals is required to identify situations in which prescription patterns are contributing to the development of resistance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.